Ischemia Reperfusion Injury Therapeutics (IRIT) Market Analysis-2027

1. ISCHEMIA REPERFUSION INJURY THERAPEUTICS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Ischemia Reperfusion Injury Therapeutics Market - Overview The Global Ischemia Reperfusion Injury Therapeutics Market, by Indication (Heart Injury, Kidney Injury, Intestine Injury, and Other Injury), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 1,582.3 million in 2020 and is expected to exhibit a CAGR of 5.4% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights. There is no established treatment for ischemia reperfusion injury till now. Being a niche and capital intensive therapy area, companies are collaborating in order to synergize their strengths and develop a treatment. For instance, in May 2019, Abiomed received an FDA approval for its STEM DTU trial of delayed ischemic reperfusion injury. This clinical trial will test the hypothesis that unloading the left ventricle for 30 minutes before ischemia and reperfusion injury (IRI) to reduce myocardial damage from a heart attack and decrease in the heart failure-related events in future. In January 2020, a cannabis life sciences company, Revive Therapeutics Ltd., provided an update regarding its clinical development plan on liver diseases. Browse Research Reports: https://www.coherentmarketinsights.com/market- insight/ischemia-reperfusion-injury-therapeutics-market-4105 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Browse 26 Market Data Tables and 28 Figures spread through 156 Pages and in- depth TOC on Ischemia Reperfusion Injury Therapeutics Market, by Indication (Heart Injury, Kidney Injury, Intestine Injury, and Other Injury), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Forecast to 2027" The emergence of drugs for treatment of complications related to ischemia reperfusion and rising number of research & development activities are some of the factors driving growth of the global ischemia reperfusion injury therapeutics. For instance, Faraday Pharmaceuticals in November 2019, announced phase II clinical trials’ positive top-line results of FDY-5301, for ischemia and reperfusion injury treatment. Key Takeaways of the Global Ischemia Reperfusion Injury Therapeutics Market: The global ischemia reperfusion injury therapeutics market is expected to exhibit a CAGR of 5.4% during the forecast period (2020-2027) owing to increasing research & development of novel therapies and treatments for ischemia and reperfusion injury. Request a Sample copy of this reports : https://www.coherentmarketinsights.com/insight/request-sample/4105 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Among distribution channel, the hospital pharmacy segment is expected to hold the largest revenue share in the market in 2027 owing to the rising number of tissue damage cases and ischemia and reperfusion injury. This is mainly because ischemia reperfusion injury is the tissue damage that arises when blood supply returns to the tissue (reperfusion) due to lack of oxygen (ischemia). Major players operating in the global ischemia reperfusion injury therapeutics market are Omeros Corporation, Pharming Group N.V., Nyken B.V., Orexo AB, Opsona Therapeutics Limited, PledPharma AB, Pharmaceuticals LLC, Prolong Pharmaceuticals, Stealth BioTherapeutics Inc., Zealand Pharma A/S, Antipodean Pharmaceuticals, Inc., Bayer AG, Angion Biomedica Corp., Bolder Biotechnology, Inc., Curatis Pharma Corporation, Ensemble Therapeutics Corporation, Gilead Sciences, Inc., and Erimos Pharmaceuticals, LLC. Prothix BV, Proteo, Inc., Amyndas GmbH, Biomedica Management Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/4105 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved